Lobby groups question cosmetic nano ingredients
Eight lobby groups in the US have combined to petition the USFDA into tightening regulations over nanotechnology-based ingredients contained in sunscreens and other cosmetics products.
Archives for May 17, 2006
Lonza buys Larex's arabinogalactan assets
Swiss biotech company Lonza has announced the latest move to expand its ingredients portfolio, with the acquisition of the larch arabinogalactan assets of US firm Larex.